Clinical trial
Expression of Inflammatory Mediators in Induced Sputum: A Potential Biomarker of Drug Response in COPD
NCT00233051 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expression of Inflammatory Mediators in Induced Sputum: A Potential Biomarker of Drug Response in COPD
- Lead sponsor
- National Jewish Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2003
- Completion date
- June 30, 2006
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic bronchitis, chronic obstructive pulmonary disease (copd), emphysema